Home » Topics » BioWorld Science

BioWorld Science
RSS

Dual M3 and 5-HT4 antagonists claimed in recent patent by Sanofi-Synthelabo

Oct. 29, 2001

AtheroGenics updates product developments during third quarter

Oct. 29, 2001

Acapodene advances to next phase of clinical trials as prostate cancer preventive

Oct. 29, 2001

GenVec continues to make advances with gene-based drug candidates

Oct. 29, 2001

EB-1089 exerts significant chemopreventive effect in animal model of hepatocarcinoma

Oct. 29, 2001

Preliminary analysis of phase II data for LY-355703 results in trial suspension

Oct. 29, 2001

MGI Pharma updates Q3 developments

Oct. 29, 2001

Combinations of Janssen farnesyltransferase inhibitor with other chemotherapeutic agents

Oct. 29, 2001

Feasibility of different schedule of administration assessed for ET-743 in clinical trial

Oct. 29, 2001

Vertex highlights Q3 2001 progress

Oct. 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...